• Research, Science, and Trials

  FA Patients May Benefit From MS Therapy Dimethyl Fumarate, Study Says

  Posted by fa-forums-moderator on June 18, 2019 at 2:13 pm

  

  Treatment with the approved multiple sclerosis therapy dimethyl fumarate may be beneficial for patients with Friedreich’s ataxia, researchers say. Read more about it here.

  What do you think of this news?

  replied 4 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply